KMDA remains a buy as it delivers strong earnings growth, robust cash generation, and trades at a discount to healthcare peers with an attractive FCF yield. Q2 results confirm ongoing operating ...
Unlike the last super cycle spurred by a peak in interest rates, globalization, and the collapse of the Soviet Union, the next will be spurred by AI.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback